Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
24 Abril 2024 - 8:00AM
Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the
“Company”), a medical device company focused on advancing
innovative technologies to revolutionize how diseases involving the
nervous system are diagnosed and treated, today announced that Lori
Bisson, Chief Executive Officer of Autonomix, will present and
discuss recent corporate events at LIVE! with Webull Corporate
Connect: Virtual Biotech Investment Webinar on Wednesday, May 1,
2024 at 3:20 PM ET.
Conference Details:
Conference: LIVE! with Webull
Corporate Connect: Virtual Biotech Investment Webinar
Date/Time: Wednesday, May 1st
at 3:20 PM ET
Presenter: Lori Bisson, Chief
Executive Officer
Registration Link: HERE
About Webull Financial
Webull Financial is a leading online brokerage
platform committed to empowering self-directed investors with
innovative tools and cutting-edge technology. With low-cost trading
on a wide range of assets, advanced charting tools and real-time
market data, Webull is revolutionizing the way individuals approach
investing. The user-centric approach and commitment to staying at
the forefront of industry trends underscores the mission to provide
a seamless and rewarding experience for traders of all levels.
Through the Webull Group, Webull Financial and its affiliates, they
combine to serve tens of millions of users from over 180 countries
worldwide. Securities and futures trading is offered to customers
by Webull Financial LLC ("Webull Financial"), a broker-dealer
registered with the Securities and Exchange Commission (SEC) and a
futures commission merchant registered with the Commodity Futures
Trading Commission (CFTC). Webull Financial is a member of the
Financial Industry Authority (FINRA), the National Futures
Association (NFA), and the Securities Investor Protection
Corporation (SIPC). All investing is subject to risk, including the
possible loss of principal. For more information about Webull,
visit www.webull.com.
About Autonomix Medical,
Inc.
Autonomix is a medical device company focused on
advancing innovative technologies to revolutionize how diseases
involving the nervous system are diagnosed and treated. The
Company’s first-in-class technology platform includes a
catheter-based microchip sensing array that has the ability to
detect and differentiate neural signals with approximately 3,000
times greater sensitivity than currently available technologies. We
believe this will enable, for the first time ever, transvascular
diagnosis and treatment of diseases involving the peripheral
nervous system virtually anywhere in the body.
We are initially developing our technology for
pancreatic cancer pain, a condition that can cause debilitating
pain and needs an effective solution. However, our technology
constitutes a platform with the potential to address dozens of
indications, including in cardiology, renal denervation and chronic
pain management across a wide disease spectrum.
For more information, visit autonomix.com and
connect with the Company on X, LinkedIn, Instagram and
Facebook.
Investor and Media Contact
JTC Team, LLCJenene
Thomas833-475-8247autonomix@jtcir.com
Autonomix Medical (NASDAQ:AMIX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Autonomix Medical (NASDAQ:AMIX)
Gráfica de Acción Histórica
De May 2023 a May 2024